Vol. 36. No. 2


In this issue of Seminars in Cutaneous Medicine and Surgery, we focus on providing readers with a comprehensive understanding of the current state of knowledge, as well as major knowledge gaps, of HS.

Medical management of hidradenitis suppurativa

Lauren AV Orenstein, MD | Robert G Micheletti, MD

This review will focus on the outcome measures driving clinical research in hidradenitis suppurativa, as well as existing data on systemic agents used in medical management of hidradenitis suppurativa, including antibiotics, hormonal therapies, and biologics.


Complications of hidradenitis suppurativa

Haley Naik, MD, MHSc | Joyce T Yuan, MD

Repeated episodes of profound inflammation in HS can lead to a number of complications in patients who are often otherwise young, active, and healthy.


Major gaps in understanding and treatment of hidradenitis suppurativa

Afsaneh Alavi, MD, MSc | Amit Garg, MD | Iltefat H. Hamzavi, MD | Lauren K Hoffman, BS | Michelle A Lowes, MBBS, PhD | Mondana H Ghias, BS

This paper outlines the current major questions and research gaps in HS, updated from van der Zee et al and Ingram et al and suggests some initial approaches to address each of these gaps.